07:00 , Sep 12, 2011 |  BC Week In Review  |  Company News

Amira, Bristol-Myers deal

Amira Pharmaceuticals Inc. , San Diego, Calif.   Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y.   Business: Pulmonary, Neurology, Cancer   Bristol-Myers completed its acquisition of Amira for $325 million in cash, plus up to...
00:11 , Sep 10, 2011 |  BC Extra  |  Company News

Bristol-Myers spins out Amira assets

Bristol-Myers Squibb Co. (NYSE:BMY) created two newcos with assets from recently acquired inflammation company Amira Pharmaceuticals Inc. The first, Panmira Pharmaceuticals LLC (San Diego, Calif.), received Amira's prostaglandin D2 (PGD2) receptor ( CRTH2 ; GPR44...
07:00 , Aug 1, 2011 |  BioCentury  |  Strategy

Therapeutically adjacent

Bristol-Myers Squibb Co. 's acquisition of Amira Pharmaceuticals Inc. appears at first blush to net a single compound that has completed Phase I testing in a completely new disease area for the pharma, along with...
07:00 , Jul 25, 2011 |  BC Week In Review  |  Company News

Amira, Bristol-Myers deal

Bristol-Myers will acquire Amira for $325 million in cash, plus up to $150 million in milestones. Bristol-Myers will gain Amira's AM152 , an oral lysophosphatidic acid receptor 1 ( LPA1 ) antagonist that has completed...